Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
400.3 EUR | +0.23% |
|
0.00% | +8.22% |
Jul. 09 | UBS Cuts Price Target on Linde to $475 From $490, Maintains Neutral Rating | MT |
Jul. 01 | Linde plc(NasdaqGS:LIN) dropped from Russell 3000 Growth Index | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.27 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Revenue estimates are regularly revised downwards for the current and coming years.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.22% | 209B | - | ||
-5.77% | 56.83B | A | ||
+34.24% | 13.21B | B | ||
+55.44% | 8.87B | C+ | ||
+26.80% | 3.39B | C+ | ||
+13.60% | 3.05B | C- | ||
-33.69% | 2.6B | D+ | ||
+7.32% | 2.18B | - | ||
-12.41% | 2.1B | - | ||
-26.11% | 1.17B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- LIN Stock
- Ratings Linde plc